Eltrombopag


( Last Updated : March 31, 2014)
Generic Name:
Eltrombopag
Project Status:
Complete
Therapeutic Area:
Thrombocytopenia associated with chronic hepatitis c infection
Manufacturer:
GlaxoSmithKline
Call for patient/clinician input open:
Brand Name:
Revolade
Project Line:
Reimbursement Review
Project Number:
SR0377-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Thrombocytopenia associated with chronic hepatitis c infection
Recommendation Type:
List with criteria/condition
Final Recommendation: